U. Søgaard, J. Michalow, B. Butler, A. Lund Laursen, S. H. Ingersen, B. K. Skrumsager, O. J. Rafaelsen: A Tolerance Study of Single and Multiple Dosing of the Selective Dopamine Uptake Inhibitor GBR 12909 in Healthy Subjects. In: International Clinical Psychopharmacology. Band5, Nr.4, Oktober 1990, S.237, doi:10.1097/00004850-199010000-00001.
David A. Gorelick, Eliot L. Gardner, Zheng-Xiong Xi: Agents in Development for the Management of Cocaine Abuse. In: Drugs. Band64, Nr.14, 1. Juli 2004, S.1547–1573, doi:10.2165/00003495-200464140-00004.
Barbara H. Herman, Ahmed Elkashef, Frank Vocci: Medications for the treatment of cocaine addiction: Emerging candidates. In: Drug Discovery Today: Therapeutic Strategies. Band2, Nr.1, März 2005, S.87–92, doi:10.1016/j.ddstr.2005.05.014.
Antonio E. Lacerda, Yuri A. Kuryshev, Gan‐Xin Yan, Albert L. Waldo, Arthur M. Brown: Vanoxerine: Cellular Mechanism of a New Antiarrhythmic. In: Journal of Cardiovascular Electrophysiology. Band21, Nr.3, März 2010, S.301–310, doi:10.1111/j.1540-8167.2009.01623.x, PMID 19817928.
Ana Isabelle G. Queiroz, Maíra Moraes de Araújo, Tatiane da Silva Araújo, Greicy Coelho de Souza, Lígia Menezes Cavalcante, Michel de Jesus Souza Machado, David Freitas de Lucena, João Quevedo, Danielle Macêdo: GBR 12909 administration as an animal model of bipolar mania: time course of behavioral, brain oxidative alterations and effect of mood stabilizing drugs. In: Metabolic Brain Disease. Band30, Nr.5, 1. Oktober 2015, S.1207–1215, doi:10.1007/s11011-015-9697-6.
Jared W. Young, Andrew K. L. Goey, Arpi Minassian, William Perry, Martin P. Paulus, Mark A. Geyer: GBR 12909 administration as a mouse model of bipolar disorder mania: mimicking quantitative assessment of manic behavior. In: Psychopharmacology. Band208, Nr.3, 1. Februar 2010, S.443–454, doi:10.1007/s00213-009-1744-8, PMID 20020109.
drugbank.com
go.drugbank.com
Vanoxerine. DrugBank online, 2022, abgerufen am 15. Mai 2024 (englisch).
jneurosci.org
Srihari R. Tella, Bruce Ladenheim, Anne M. Andrews, Steven R. Goldberg, and Jean Lud Cadet: Differential Reinforcing Effects of Cocaine and GBR-12909:
Biochemical Evidence for Divergent Neuroadaptive Changes in the
Mesolimbic Dopaminergic System. In: The Journal of Neuroscience. Band16, Nr.23, 1996, S.7416–7427 (jneurosci.org [PDF; abgerufen am 15. Mai 2024]).
nih.gov
ncbi.nlm.nih.gov
Antonio E. Lacerda, Yuri A. Kuryshev, Gan‐Xin Yan, Albert L. Waldo, Arthur M. Brown: Vanoxerine: Cellular Mechanism of a New Antiarrhythmic. In: Journal of Cardiovascular Electrophysiology. Band21, Nr.3, März 2010, S.301–310, doi:10.1111/j.1540-8167.2009.01623.x, PMID 19817928.
Jared W. Young, Andrew K. L. Goey, Arpi Minassian, William Perry, Martin P. Paulus, Mark A. Geyer: GBR 12909 administration as a mouse model of bipolar disorder mania: mimicking quantitative assessment of manic behavior. In: Psychopharmacology. Band208, Nr.3, 1. Februar 2010, S.443–454, doi:10.1007/s00213-009-1744-8, PMID 20020109.